Sunesis Pharmaceuticals Stock Price

0.00 (0.0%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Sunesis Pharmaceuticals Inc SNSS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 5.32 19:00:00
Open Price Low Price High Price Close Price Prev Close
Bid Price Ask Price Spread News
4.72 4.75 0.03 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 5.32 USD

Sunesis Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 96.34M 18.11M 17.59M $ 2.07M $ - -2.89 -1.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Sunesis Pharmaceuticals News

Date Time Source News Article
2/25/202118:04Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)
2/24/202116:38Edgar (US Regulatory)Current Report Filing (8-k)
2/24/202111:24Seeking AlphaSunesis Pharma continues momentum after Q4 earnings beat..
2/24/202106:08Edgar (US Regulatory)Annual Report (10-k)
2/23/202112:44Seeking AlphaCCIV, SNSS, RIOT and EVER among midday movers
2/23/202106:05Edgar (US Regulatory)Current Report Filing (8-k)
2/16/202116:05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SNSS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.637.08643.534.9039,031,6111.6946.56%
1 Month2.567.08642.494.777,520,2322.76107.81%
3 Months1.757.08641.724.163,065,7963.57204.0%
6 Months0.2787.08640.1612.602,559,5105.041,813.67%
1 Year1.027.08640.1610.91164614,975,3664.30421.57%
3 Years6.757.690.1610.90424972,186,358-1.43-21.19%
5 Years0.787.690.1610.96591481,391,4964.54582.05%

Sunesis Pharmaceuticals Description

Sunesis Pharmaceuticals Inc is a US-based biopharmaceutical company. It focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The product portfolio of the company includes Vosaroxin which is an anticancer quinolone derivative for the treatment of acute myeloid leukemia (AML). The company's other kinase inhibitor pipeline includes TAK-580, SNS-062, and SNS-229. Further, the firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The firm derives substantially the majority of revenue from license and collaboration agreements.
Your Recent History
Sunesis Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210301 17:35:40